I. Cockburn

发表

Entry and Patenting in the Software Industry

Iain M. Cockburn, Megan J. MacGarvie, I. Cockburn, 2006, Manag. Sci..

Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery

I. Cockburn, R. Henderson, 2003 .

The Impact of Artificial Intelligence on Innovation: An Exploratory Analysis

I. Cockburn, R. Henderson, Scott Stern, 2018 .

Measuring competence?: exploring firm effects in pharmaceutical research

I. Cockburn, R. Henderson, 1994 .

Scale, scope, and spillovers: the determinants of research productivity in drug discovery.

I. Cockburn, R. Henderson, I Cockburn, 1996, The Rand journal of economics.

Analysis of Patent Data—A Mixed-Poisson-Regression-Model Approach

Martin L. Puterman, Iain M. Cockburn, Peiming Wang, 1998 .

Mixed Poisson regression models with covariate dependent rates.

M. Puterman, I. Cockburn, P. Wang, 1996, Biometrics.

Industry Effects and Appropriability Measures in the Stock Markets Valuation of R&D and Patents

Z. Griliches, I. Cockburn, 1987 .

Patent Thickets, Licensing and Innovative Performance

Megan J. MacGarvie, I. Cockburn, Elisabeth Müller, 2010 .

Untangling the origins of competitive advantage

I. Cockburn, R. Henderson, Scott Stern, 2011 .

Opportunity costs and entrepreneurial activity

E. Muller, I. Cockburn, R. Amit, 1995 .

Publicly Funded Science and the Productivity of the Pharmaceutical Industry

I. Cockburn, R. Henderson, 2000, Innovation Policy and the Economy.

The Foundations of Entrepreneurial Strategy

Thomas R. Eisenmann, David H. Hsu, Wesley M. Cohen, 2016 .

The Economics of Reproducibility in Preclinical Research

I. Cockburn, L. Freedman, Timothy S. Simcoe, 2015, PLoS biology.

Gone but not Forgotten: Knowledge Flows, Labor Mobility, and Enduring Social Relationships

A. Agrawal, I. Cockburn, J. Mchale, 2006 .

Measuring Competence? Exploring Firm Effects in Drug Discovery

I. Cockburn, R. Henderson, 1994 .

Racing To Invest? The Dynamics of Competition in Ethical Drug Discovery

I. Cockburn, R. Henderson, 1994 .

Scale, Scope and Spillovers: The Determinants of Research Productivity in the Pharmaceutical Industry

I. Cockburn, R. Henderson, 1993 .

THE 2003 INTELLECTUAL PROPERTY OWNERS ASSOCIATION SURVEY ON THE STRATEGIC MANAGEMENT OF INTELLECTUAL PROPERTY IN AMERICA'S CORPORATIONS

I. Cockburn, R. Henderson, 2003 .

Patents, Thickets and the Financing of Early-Stage Firms: Evidence from the Software Industry

Megan J. MacGarvie, I. Cockburn, 2007 .

Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research.

I. Cockburn, R. Henderson, I M Cockburn, 2001, Journal of health economics.

New Pills for Poor People? Empirical Evidence after GATT

Iain M. Cockburn, Jean O. Lanjouw, I. Cockburn, 2001 .

The Diffusion of Science-Driven Drug Discovery: Organizational Change in Pharmaceutical Research

Scott Stern, I. Cockburn, R. Henderson, 1999 .

Patents and the Survival of Internet-Related Ipos

Stefan Wagner, I. Cockburn, Stefan Wagner, 2007 .

Intellectual property and the survival of internet-related NASDAQ-IPOs October 14 , 2005 CONFERENCE DRAFT ONLY

I. Cockburn, Stefan Wagner, 2005 .

Gone But Not Forgotten: Labor Flows, Knowledge Spillovers, and Enduring Social Capital

John McHale, A. Agrawal, I. Cockburn, 2003 .

1 Clusters , Convergence , and Economic Performance

Wayne D. Gray, Megan J. MacGarvie, M. Porter, 2011 .

Contracting Over the Disclosure of Scientific Knowledge: Intellectual Property Protection and Academic Publication

Mark A. Lemley, Heidi L. Williams, J. Gans, 2010 .

Intellectual Property Rights and Pharmaceuticals: Challenges and Opportunities for Economic Research

I. Cockburn, 2009 .

Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs

Z. Griliches, I. Cockburn, E. Berndt, 1997 .

The Economics of Reproducibility in

I. Cockburn, L. Freedman, Timothy S. Simcoe, 2015 .

The Global Location of Biopharmaceutical Knowledge Activity: New Findings, New Questions

I. Cockburn, M. Slaughter, 2010, Innovation Policy and the Economy.

Is the Pharmaceutical Industry in a Productivity Crisis?

Iain M. Cockburn, I. Cockburn, 2006, Innovation Policy and the Economy.

Access to Intellectual Property for Innovation: Evidence on Problems and Coping Strategies from German Firms

Megan J. MacGarvie, I. Cockburn, Elisabeth Müller, 2010 .

A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998.

I. Cockburn, R. Stafford, Jun Ma, 2003, Clinical therapeutics.

National trends in asthma visits and asthma pharmacotherapy, 1978-2002.

I. Cockburn, R. Stafford, Jun Ma, 2003, The Journal of allergy and clinical immunology.

Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.

I. Cockburn, C. Furberg, R. Stafford, 2004, JAMA.

Patent Prosecution And The Timing Of Licensing

Arvids A. Ziedonis, I. Cockburn, Ayfer Ali, 2018, Academy of Management Proceedings.

NBER WORKING PAPER SERIES NOWCASTING AND PLACECASTING ENTREPRENEURIAL QUALITY AND PERFORMANCE

Ezra W. Zuckerman, J. Gans, H. Varian, 2015 .

BUYER BEHAVIOR IN MARKETS FOR TECHNOLOGY: TECHNOLOGY PROXIMITY BETWEEN FIRM PORTFOLIO AND IN-LICENSED PATENTS

I. Cockburn, Ayfer Ali, 2012 .

THE GLOBALIZATION OF CLINICAL TRIALS FOR NEW MEDICINES INTO EMERGING ECONOMIES: WHERE ARE THEY GOING AND WHY?

I. Cockburn, E. Berndt, F. A. Thiers, 2007 .

The importance of patents to innovation: updated cross-industry comparisons with biopharmaceuticals

I. Cockburn, Genia Long, 2015, Expert opinion on therapeutic patents.

The hidden cost of low prices: limited access to new drugs in India.

I. Cockburn, E. Berndt, 2014, Health affairs.

Information Technology and Intangible Output: The Impact of IT Investment on Innovation Productivity

Landon Kleis, Iain M. Cockburn, Paul Chwelos, 2012, Inf. Syst. Res..

The market for follow-on biologics: how will it evolve?

I. Cockburn, H. Grabowski, Genia Long, 2006, Health affairs.

PATENT RIGHTS AND INNOVATION BY SMALL AND LARGE FIRMS

Heidi L. Williams, Carlos J. Serrano, I. Cockburn, 2015 .

The changing structure of the pharmaceutical industry.

I. Cockburn, Iain M Cockburn, 2004, Health affairs.

Why are some regions more innovative than others? The role of small firms in the presence of large labs

Ajay Agrawal, Alberto Galasso, Iain M. Cockburn, 2014 .

Deals Not Done: Sources of Failure in the Market for Ideas

A. Agrawal, I. Cockburn, Laurina Zhang, 2013 .

Scale, Scope and Spillovers: The Determinants of Research Productivity in Ethical Drug Discovery

Rebecca Henderson, Iain M. Cockburn, I. Cockburn, 2015 .

Loss of work productivity due to illness and medical treatment.

I. Cockburn, E. Berndt, S. Finkelstein, 1999, Journal of occupational and environmental medicine.

The Anchor Tenant Hypothesis: Exploring the Role of Large, Local, R&D-Intensive Firms in Regional Innovation Systems

Ajay Agrawal, A. Agrawal, I. Cockburn, 2003 .

Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases

I. Cockburn, E. Berndt, Thomas J. Bollyky, 2010, Clinical trials.

The Impact of Incremental Innovation in Biopharmaceuticals

I. Cockburn, E. Berndt, K. Grépin, 2006, PharmacoEconomics.

Why are Some Regions More Innovative than Others? The Role of Firm Size Diversity

A. Agrawal, I. Cockburn, Alexander Oettl, 2012 .

Market Conditions and Retirement of Physical Capital: Evidence Fron Oil Tankers

Murray Z. Frank, I. Cockburn, 1992 .

Intellectual Property Rights and the Transition to the Knowledge-Based Economy

I. Cockburn, P. Chwelos, Paul Chwelos, 2001 .

Impact of Clinical Trial Results on National Trends in α-Blocker Prescribing, 1996-2002

Stan N. Finkelstein, Curt D. Furberg, Iain M. Cockburn, 2004 .

Diffusion of New Drugs in the Post-TRIPS Era

I. Cockburn, E. Berndt, Nathan Blalock, 2011 .

ARE ALL PATENT EXAMINERS EQUAL? THE IMPACT OF CHARACTERISTICS ON PATENT STATISTICS AND LITIGATION OUTCOMES

I. Cockburn, Samuel Kortum, Scott Stern, 2002 .

Patents and the Global Diffusion of New Drugs

I. Cockburn, Mark A. Schankerman, J. Lanjouw, 2014, The American economic review.

Firm Size and Research Productivity in Drug Discovery . Revised Jan 1997

I. Cockburn, R. Henderson, 2001 .

Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Energy R&D

Scott Stern, Iain M. Cockburn, Jack Zausner, 2011 .

The Impact of Artificial Intelligence on Innovation

Rebecca Henderson, Iain M. Cockburn, Scott Stern, 2018, The Economics of Artificial Intelligence.

Not Invented Here? Innovation in Company Towns

Ajay Agrawal, Iain M. Cockburn, Carlos Rosell, 2009 .

DO FIRMS CHANGE CAPABILITIES BY HIRING NEW PEOPLE? A STUDY OF THE ADOPTION OF SCIENCE-BASED DRUG DISCOVERY

Rebecca Henderson, Iain M. Cockburn, I. Cockburn, 2004 .

Characteristics of demand for pharmaceutical products: an examination of four cephalosporins.

Z. Griliches, I. Cockburn, J. Hausman, 1997, The Rand journal of economics.

This PDF is a selection from a published volume from the National Bureau of Economic Research Volume Title: The Rate and Direction of Inventive Activity Revisited

I. Cockburn, Scott Stern, J. Lerner, 2014 .

Generics and New Goods in Pharmaceutical Price Indexes

Zvi Griliches, Z. Griliches, I. Cockburn, 1993 .

Exploring the Link Between Academic Science and Industrial Innovation: The Case of California’s Research Universities

Rebecca Henderson, Ariel Pakes, Lee Branstetter, 2000 .

“FIT”: FIELD EXPERIMENTAL EVIDENCE ON CREATIVE WORKER SORTING ON AN INNOVATION TASK

Heidi L. Williams, Peter A. Coles, Daniel W. Elfenbein, 2011 .

Price Indexes for Clinical Trial Research: A Feasibility Study

I. Cockburn, E. Berndt, Ernst R. Berndt, 2013 .

Firm Size Diversity and Regional Innovation

Ajay Agrawal, Alberto Galasso, Iain M. Cockburn, 2011 .

Faster, smaller, cheaper: an hedonic price analysis of PDAs

I. Cockburn, E. Berndt, P. Chwelos, 2004 .

Pharmaceutical Innovations and Market Dynamics: Tracking Effects on Price Indexes for Antidepressant Drugs

Z. Griliches, I. Cockburn, E. Berndt, 1996 .

Arthritis Drugs

I. Cockburn, A. Anis, 2001 .

Are All Patent Examiners Equal? The Impact of Examiner Characteristics

Scott Stern, I. Cockburn, Samuel Kortum, 2002 .

Preliminary*and*incomplete.*do*not*cite*or*circulate*without*permission* * 0* * Healthcare Exceptionalism? Productivity and Allocation in the U.s. Healthcare Sector + * Preliminary*and*incomplete.*do*not*cite*or*circulate*without*permission* * 1* *

Heidi L. Williams, J. Skinner, I. Cockburn, 2012 .

Public-Private Interaction and the Productivity of Pharmaceutical Research

I. Cockburn, R. Henderson, Iain M. Cockburn, 1997 .

Hedonic Analysis of Arthritis Drugs

I. Cockburn, A. Anis, 1998 .

2 Balancing Incentives in Pharmaceutical Research

I. Cockburn, R. Henderson, 2004 .

An Exploratory Analysis

I. Cockburn, R. Henderson, 2020 .

NBER WORKING PAPER SERIES PATENTS AND THE GLOBAL DIFFUSION OF NEW DRUGS

I. Cockburn, J. Lanjouw, 2014 .

Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research

Rebecca Henderson, Jeffrey L. Furman, Iain M. Cockburn, 2006 .

Do Patents Matter?: Empirical Evidence after GATT

I. Cockburn, J. Lanjouw, Iain M. Cockburn, 2000 .

The Changing Structure Of The Pharmaceutical Industry Drug development under today's new institutional arrangements could turn out to be faster and better, but not cheaper.

I. Cockburn, 2004 .

The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity

Bradley T. Shapiro, I. Cockburn, B. Bosworth, 2013 .

The Diffusion of Science-Driven Drug Discovery: Organizational Change in Pharmaceutical Research

I. Cockburn, Rebecca Henderson, Scott Stern, 1999 .

Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Technology Policy

Scott Stern, Iain M. Cockburn, I. Cockburn, 2010 .

Innovation and the Firm Size Diversity Hypothesis

A. Agrawal, I. Cockburn, Alexander Oettl, 2011 .